Evidence map›Paper›PMID 30842647›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Elucidation of the phenotypic spectrum and genetic landscape in primary and secondary microcephaly.

Paranchai Boonsawat, Pascal Joset, Katharina Steindl, Beatrice Oneda, Laura Gogoll, Silvia Azzarello-Burri, Frenny Sheth, Chaitanya Datar, Ishwar C Verma, Ratna Dua Puri and 22 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Genes · 2026
    Pooled it
  2. Article
  3. Enzymology of the metazoan tRNA ligase complex: a lifetime in cycles.Cellular and molecular life sciences : CMLS · 2026
    Review
  4. Translational pediatrics · 2026
    Article
  5. Human mutation · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Homozygous Intragenic Deletion inMolecular syndromology · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 10 institutions in 7 countries.

Paranchai BoonsawatInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Pascal JosetInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Katharina SteindlInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Beatrice OnedaInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Laura GogollInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Silvia Azzarello-BurriInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Frenny ShethFRIGE's Institute of Human Genetics, FRIGE House, Satellite, Ahmedabad, India.
Chaitanya DatarSahyadri Medical Genetics and Tissue Engineering Facility, Kothrud, Pune and Bharati Hospital and Research Center Dhankawadi, Pune, India.
Ishwar C VermaInstitute of Medical Genetics & Genomics, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, India.
Ratna Dua PuriInstitute of Medical Genetics & Genomics, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, India.
Marcella ZollinoUnità Operativa Complessa di Genetica Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, and Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Rome, Italy.
Ruxandra Bachmann-GagescuInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Dunja NiedristInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Michael PapikInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Joana Figueiro-SilvaInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Rahim MasoodInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Markus ZweierInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Dennis KraemerInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Sharyn LincolnDivision of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Lance RodanDivision of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Undiagnosed Diseases Network (UDN)
Sandrine PassemardService de Neuropédiatrie, Hôpital Universitaire Robert Debré, APHP, Paris, France.
Séverine DrunatDépartement de Génétique, Hôpital Universitaire Robert Debré, APHP, Paris, France.
Alain VerloesDépartement de Génétique, Hôpital Universitaire Robert Debré, APHP, Paris, France.
Anselm H C HornDivision of Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Heinrich StichtDivision of Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Robert SteinfeldDivision of Pediatric Neurology, University Children's Hospital Zurich, Zurich, Switzerland.
Barbara PleckoDivision of Pediatric Neurology, University Children's Hospital Zurich, Zurich, Switzerland.
Beatrice LatalChild Development Center, University Children's Hospital Zurich, Zurich, Switzerland.
Oskar JenniChild Development Center, University Children's Hospital Zurich, Zurich, Switzerland.
Reza AsadollahiInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland.
Anita RauchInstitute of Medical Genetics, University of Zurich, Schlieren, Zurich, Switzerland. anita.rauch@medgen.uzh.ch.
University of Zurich · CHUniversity Children's Hospital Zurich · CHBoston Children's Hospital · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHôpital Robert-Debré · FRSir Ganga Ram Hospital · INAssistance Publique – Hôpitaux de Paris · FRMedical University of Graz · ATSahyadri Hospital · INUniversità Cattolica del Sacro Cuore · IT

Funding

Center for Integrated Approaches to Undiagnosed DiseasesU01HG007690 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 2014 to 2022
$10.4M
Clinical Genome Wide Sequencing Core for the Undiagnosed Disease NetworkU01HG007943 · NHGRI · MEDICAL COLLEGE OF WISCONSIN · PI WORTHEY, ELIZABETH A · 2014 to 2017
$4.1M
NHGRI NIH HHS U01 HG007690NHGRI NIH HHS U01 HG007943
6 · The paper itself

Abstract

purposeMicrocephaly is a sign of many genetic conditions but has been rarely systematically evaluated. We therefore comprehensively studied the clinical and genetic landscape of an unselected cohort of patients with microcephaly.

methodsWe performed clinical assessment, high-resolution chromosomal microarray analysis, exome sequencing, and functional studies in 62 patients (58% with primary microcephaly [PM], 27% with secondary microcephaly [SM], and 15% of unknown onset).

resultsWe found severity of developmental delay/intellectual disability correlating with severity of microcephaly in PM, but not SM. We detected causative variants in 48.4% of patients and found divergent inheritance and variant pattern for PM (mainly recessive and likely gene-disrupting [LGD]) versus SM (all dominant de novo and evenly LGD or missense). While centrosome-related pathways were solely identified in PM, transcriptional regulation was the most frequently affected pathway in both SM and PM. Unexpectedly, we found causative variants in different mitochondria-related genes accounting for ~5% of patients, which emphasizes their role even in syndromic PM. Additionally, we delineated novel candidate genes involved in centrosome-related pathway (SPAG5, TEDC1), Wnt signaling (VPS26A, ZNRF3), and RNA trafficking (DDX1).

conclusionOur findings enable improved evaluation and genetic counseling of PM and SM patients and further elucidate microcephaly pathways.

Indexed as

Genetic Predisposition to DiseaseAdolescentCell Cycle ProteinsChildChild, PreschoolDEAD-box RNA HelicasesDevelopmental DisabilitiesExomeExome SequencingFemaleGene Expression RegulationHumansInfantIntellectual DisabilityMaleMicrocephalyCell Cycle ProteinsDDX1 protein, humanDEAD-box RNA HelicasesSPAG5 protein, humanUbiquitin-Protein LigasesZNRF3 protein, humangenetic counselingMCPHmitochondriaprimary microcephalysecondary microcephaly

Identifiers

PMID30842647
PMCPMC6752480
OpenAlexW2919935718

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.